Posted: Mon., Oct. 1, 2007, 3:25pm PT

Broadway bounces back

Ticket sales continue to climb

Few Broadway shows saw sales rise drastically last week, but most of them were up, with total cume for 24 productions on the boards climbing about $375,000 to $14.3 million.

"Mary Poppins" ($884,744) got the largest bump of the week, stepping up more than $85,000, while "Spring Awakening" (up almost $70,000 to $667,131) and "The Drowsy Chaperone" (rising more than $60,000 to $507,312) also logged noteworthy upticks in sales.

Among the seven shows to slide last week, most saw negligible shortfalls, with the exceptions being "The Color Purple," which fell more than $75,000 to $733,073, and "The Phantom of the Opera," down more than $55,000 to $570,540. "Grease" ($719,404) slowed by about $30,000.

The Roundabout's revival of "Pygmalion" ($287,129) went from four perfs the prior frame to a full week of eight shows last week and had $145,000 more to show for it, while among other previewing plays, "The Ritz" ($281,112) rose a bit and "Mauritius" ($186,793) was down slightly over a weekend of press perfs.

The real shakeup to autumn sales on Broadway will come next week, when "Young Frankenstein" begins previews Oct. 11 -- and legiters will scramble to find out sales tallies for the Mel Brooks tuner, producers of which have decided not to report grosses.


TALKBACK:

Have an opinion about this article? Be the first to comment




Tressa, one of the many stars of A&E's 'Intervention,' talks about her lengthy battle with methamphetamine. ; reality show; intervention; A&E; emmy contenders; drug addicts; variety; Interviews with Erick McCormack, Daniel Dae Kim & Christa Miller, stars of A&E's new sci-fi thriller, 'The Andromeda Strain.'; Erick McCormack; A&E; tv; sci-fi; The Andromeda Strain; variety; Daniel Dae Kim & Christa Miller;


Q What are the top 3 things affecting our industry today?
A. Matthew - The drama, the way people are being treated through the media, and the ongoing effects of ... more >


Submit this form
© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.